化合物GAL021 T3557
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 1380341-99-0 | ¥828.00 | 询底价 |
500 mg | 1380341-99-0 | ¥11,300.00 | 询底价 |
25 mg | 1380341-99-0 | ¥2,260.00 | 询底价 |
10 mg | 1380341-99-0 | ¥1,230.00 | 询底价 |
50 mg | 1380341-99-0 | ¥3,730.00 | 询底价 |
2 mg | 1380341-99-0 | ¥478.00 | 询底价 |
1 mg | 1380341-99-0 | ¥335.00 | 询底价 |
1 mL | 1380341-99-0 | ¥861.00 | 询底价 |
100 mg | 1380341-99-0 | ¥5,420.00 | 询底价 |
Product Introduction
Bioactivity
英文名: GAL-021
描述: GAL-021新型静脉内BKCa-channel 阻滞剂。
激酶实验: GAL-021 is dissolved in DMSO, and final assay concentration of DMSO is 0.1% or less. The effects of GAL-021 (30 μM) on a panel of 55 receptors, transporters, and ion channels are evaluated using radioligand binding analyses. Potential kinase inhibition by GAL-021 (10 μM) is assessed using the Kinase HotSpot Screen where activity of 50 kinases is measured in the presence of adenosine triphosphate (10 μM)[1].
体外活性: Using inside-out patches in GH3 cells, GAL-021 concentration-dependently inhibits single-channel KCa1.1 activity. When evaluated against 12 different cardiac ion channels, inhibition is 35% or less at 30 μM. No significant kinase inhibition is observed at 10 μM. At 30 μM in the radioligand binding assays, interactions (defined as >50% radioligand displacement) are detected at adenosine A1 (65% I), A2A (79% I, IC50: 5 μM), and A3 (93% I; IC50: 1 μM) receptors, at 5-HT2B receptors (60% I; IC50: 30 μM).
体内活性: GAL-021 (i.v.) attenuates opiate-induced respiratory depression in rats and nonhuman primates without affecting morphine analgesia in rats. GAL-021 ventilatory stimulation in rats is attenuated by carotid sinus nerve transection. GAL-021 ventilatory stimulation is attenuated in mice lacking the pore-forming α-subunit of the KCa 1.1 channel.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (196.59 mM)
关键字: KCa1.1 | minute ventilation | inhibit | BKCa | Inhibitor | KcsA | breathing control modulator | GH3 cells | Potassium Channel | GAL-021 | GAL021 | almitrine pharmacophore
相关产品: Oleandrin | DCEBIO | Tolbutamide | Phenformin hydrochloride | Dronedarone | Novobiocin Sodium | κM-Conotoxin RIIIK | (-)-Denudatin B | Glimepiride | BSH-IN-1
相关库: Ion Channel Inhibitor Library | Drug Repurposing Compound Library | ReFRAME Related Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Clinical Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Target-Focused Phenotypic Screening Library | Bioactive Compound Library
化合物GAL021 T3557信息由TargetMol中国为您提供,如您想了解更多关于化合物GAL021 T3557报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途